Bio Non Current Liabilities Total from 2010 to 2024
| BIO Stock | USD 338.48 0.00 0.00% |
Non Current Liabilities Total | First Reported 1985-12-31 | Previous Quarter 2.4 B | Current Value 2.6 B | Quarterly Volatility 927.8 M |
Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 481.6 M, as well as many indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
Bio | Non Current Liabilities Total |
Latest Bio Rad's Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of Bio Rad Laboratories over the last few years. It is Bio Rad's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
| Timeline |
Bio Non Current Liabilities Total Regression Statistics
| Arithmetic Mean | 1,574,343,727 | |
| Geometric Mean | 1,033,805,864 | |
| Coefficient Of Variation | 73.57 | |
| Mean Deviation | 1,007,584,702 | |
| Median | 953,651,000 | |
| Standard Deviation | 1,158,176,002 | |
| Sample Variance | 1341371.7T | |
| Range | 3.4B | |
| R-Value | 0.89 | |
| Mean Square Error | 303511.9T | |
| R-Squared | 0.79 | |
| Slope | 230,167,244 | |
| Total Sum of Squares | 18779203.1T |
Bio Non Current Liabilities Total History
About Bio Rad Financial Statements
Bio Rad investors utilize fundamental indicators, such as Non Current Liabilities Total, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Total | 3 B | 3.2 B |
Pair Trading with Bio Rad
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.Moving against Bio Stock
| 0.43 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.43 | ICU | LMF Acquisition Oppo | PairCorr |
| 0.38 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.34 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Bio Rad Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.412 | Earnings Share (28.06) | Revenue Per Share 90.815 | Quarterly Revenue Growth 0.028 | Return On Assets 0.0186 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.